The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s companion animal arthritis market report forecasts the companion animal arthritis market size to grow to $4.72 Billion by 2027, with a CAGR (compound annual growth rate) of 8%.

Learn More On The Companion Animal Arthritis Market Report 2023 – https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Companion Animal Arthritis Market Size Forecast
The global companion animal arthritis market is expected to grow from $3.09 billion in 2022 to $3.47 billion in 2023 at a compound annual growth rate (CAGR) of 12.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The companion animal arthritis market size is expected to grow to $4.72 billion in 2027 at a CAGR of 8.0%.

North America held the largest companion animal arthritis market share.

Key Companion Animal Arthritis Market Driver ­– Rise In Trend Of Pet Adoption
For instance, according to a survey conducted by, The American Pet Products Association, a US-based not-for-profit industry association, approximately half of british homes with pets acquired at least one new animal while the country was in lockdown, while 11.3 million Americans acquired new pets during the pandemic. Additionally, in the survey, 16% of Generation Z respondents and 13% of millennials stated they had adopted a new pet during the pandemic. Therefore, the rising trend of pet adoption contributes significantly to the growth of the companion animal arthritis market.

Request for A Sample Of The Global Companion Animal Arthritis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

Key Companion Animal Arthritis Market Trend – Technological Innovation
Technological innovation benefits people by improving productivity and giving them access to freshly produced better goods and services, which raise the general standard. Major players in the industry are using monoclonal antibody therapy to treat companion animal arthritis. Monoclonal antibody therapy is used on companion animals to treat arthritis, immune-mediated disorders, chronic pain, and others. Monoclonal antibodies are antibodies produced by immune cells that are identical clones of a single parent cell. For instance, In April 2021, Zoetis, a US-based pharmaceutical company, launched LIBRELA® and SOLENSIA® in European Union, United Kingdom, and Switzerland to prevent arthritis pain in cats and dogs using monoclonal antibody therapy. It works similarly to naturally produced antibodies, with little involvement of the liver or kidneys in their metabolism and removal of gastrointestinal impact.

Companion Animal Arthritis Market Segment
1) By Type: Dogs, Cats, Other Types
2) By Indication: Osteoarthritis, Other Arthritis
3) By Treatment: Medication, Supplements, Other Treatments
4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Companion Animal Arthritis Market Major Players and Strategies
Major players in the companion animal arthritis market are Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Vetoquinol, NexGen Pharmaceuticals, Norbrook, Eltech K-Laser s.r.l., Companion Animal Health, Canine Arthritis Management, Bioiberica, Assisi Animal Health and Exubrion Therapeutics Inc.

In September 2022, Zoetis, a US-based animal health company, acquired NewMetrica for an undisclosed amount. This transaction would enhance Zoetis’ capacities throughout the continuum of care, expand our grasp of quality-of-life evaluations, and result in a more profound comprehension of an animal’s well-being. NewMetrica is a UK-based provider of scientifically-developed instruments to measure quality-of-life in animals such as canine arthritis.

The Companion Animal Arthritis Global Market Report 2023 covers regional data on companion animal arthritis market size, companion animal arthritis market trends and drivers, opportunities, strategies, and companion animal arthritis market competitor analysis. The countries covered in the companion animal arthritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The companion animal arthritis refers to a condition involving inflammation of one or more joints in companion animals such as cats, dogs, and other exotic animals. Companion animal arthritis develops in the bones when the cartilage between joints becomes rougher and more worn, forcing the bone surfaces to rub against one another.

View More Reports Related To The Companion Animal Arthritis Market –
Companion Animal Veterinary Vaccines Global Market Report 2023
Arthritis Monoclonal Antibodies Global Market Report 2023
Animal Medicine Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: